ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Final Issue Of 1988

December 9, 1988

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014

The President’s Cancer Panel publishes its annual report

May 6, 2011

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980